Clinical Trial Update: Cefiderocol PK in Patients on ECMO [Phase 1]

View source ↗

Summary

Phase 1 study investigating the pharmacokinetics of cefiderocol in sepsis patients on ECMO has completed, providing ECMO-specific PK data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Fetroja (cefiderocol)

Snippet

Sponsor: Joseph L. Kuti, PharmD | Conditions: Sepsis | Phase 1 | Status: COMPLETED